Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer

被引：0
|
作者：
Mikihiro Kusama
Tadashi Nomizu
Kenjiro Aogi
Masataka Yoshimoto
Noboru Horikoshi
Toshio Tabei
Shinzaburo Noguchi
Shigeto Miura
Norio Yoshimura
Morihiko Kimura
Kazushige Toyama
Eisei Shin
机构：
[1] Tokyo Medical University,
[2] Hoshi General Hospital,undefined
[3] National Hospital Shikoku Cancer Center,undefined
[4] Cancer Institute Hospital,undefined
[5] Japanese Foundation for Cancer Research,undefined
[6] Saitama Prefectural Cancer Center,undefined
[7] Osaka University,undefined
[8] Aichi Prefecture Cancer Center,undefined
[9] Kyoto Prefectural University,undefined
[10] Gunma Prefecture Cancer Center,undefined
[11] Shizuoka Prefecture General Hospital,undefined
[12] National Osaka Hospital,undefined
[13] Sinjyuku Breast Center Kusama Clinic,undefined
[14] International University of Health and Welfare,undefined
[15] Mita Hospital,undefined
[16] Juntendo University School of Medicine,undefined
[17] Kamiiida Daiichi General Hospital,undefined
[18] Ohta General Hospital,undefined
[19] Shizuoka Health Management Center,undefined
[20] Iseikai Hospital,undefined
来源：
Breast Cancer | 2010年 / 17卷
关键词：
Capecitabine; Breast cancer; Advanced; Metastatic; Efficacy; Safety; Four-week (Japanese) regimen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：233 / 240
页数：7
相关论文
共 50 条
  • [41] A PHASE-II STUDY OF ORAL WEEKLY 4-DEMETHOXYDAUNORUBICIN IN ADVANCED BREAST-CANCER
    SMITH, DB
    HOWELL, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (04): : 391 - 394
  • [42] Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609
    Taguchi, Tetsuya
    Yamamoto, Daigo
    Masuda, Norikazu
    Oba, Koji
    Nakayama, Takahiro
    Nagata, Takuya
    Nomura, Masaya
    Yoshidome, Katsuhide
    Yoshino, Hiroshi
    Matsunami, Nobuki
    Miyashita, Masaru
    Furuya, Yoshihiko
    Ishida, Takanori
    Wakita, Kazuyuki
    Sakamoto, Junichi
    Noguchi, Shinzaburo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 741 - 747
  • [43] Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609
    Tetsuya Taguchi
    Daigo Yamamoto
    Norikazu Masuda
    Koji Oba
    Takahiro Nakayama
    Takuya Nagata
    Masaya Nomura
    Katsuhide Yoshidome
    Hiroshi Yoshino
    Nobuki Matsunami
    Masaru Miyashita
    Yoshihiko Furuya
    Takanori Ishida
    Kazuyuki Wakita
    Junichi Sakamoto
    Shinzaburo Noguchi
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 741 - 747
  • [44] Phase II Trial of Capecitabine and Weekly Docetaxel for Metastatic Castrate Resistant Prostate Cancer
    Vaishampayan, Ulka N.
    Marur, Shanthi
    Heilbrun, Lance K.
    Cher, Michael L.
    Dickow, Brenda
    Smith, Daryn W.
    Al Hasan, Samir A.
    Eliason, James
    JOURNAL OF UROLOGY, 2009, 182 (01): : 317 - 323
  • [45] Phase II study of weekly scheduled irinotecan and capecitabine treatment in advanced colorectal cancer patients.
    Li, Wenhua
    Li, Jin
    Xu, Jianming
    Shen, Lin
    Liu, Tianshu
    Guo, Wei Jian
    Zhang, Wen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] WEEKLY OXALIPLATIN AND CAPECITABINE CONTINUOUSLY IN ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER (ACRC). A PHASE II STUDY
    Pochettino, Paolo
    Bergnolo, Paola
    Boglione, Antonella
    Dal Canton, Orietta
    Cutin, Simona Chiado
    Garetto, Ferdinando
    Biscardi, Emanuela
    Comandone, Alessandro
    ANNALS OF ONCOLOGY, 2004, 15 : 61 - 61
  • [47] Phase II trial of weekly docetaxel (DOC) and prolonged capecitabine (C) in metastatic breast cancer (MBC) patients (pts).
    Shapiro, CL
    Ramaswamy, B
    Rhoades, C
    Kendra, K
    Allen, J
    Hauger, M
    Loughlin, H
    Moore, T
    Villalona, M
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S203 - S203
  • [48] Capecitabine monotherapy: Safe and effective treatment for metastatic breast cancer
    Ershler, William B.
    ONCOLOGIST, 2006, 11 (04): : 325 - 335
  • [49] Capecitabine monotherapy for elderly patients with metastatic breast cancer.
    Minea, LN
    Stanculeanu, DL
    Cringeanu, A
    Anghel, RM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 76S - 76S
  • [50] Phase II study of perifosine in metastatic or advanced breast cancer.
    Leighl, NB
    Warr, D
    Vandenberg, T
    Dent, S
    Tannock, IF
    Crump, M
    Tozer, R
    Dancey, J
    Moore, MJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S67 - S68
12345